Pharmacology of Mood Disorders & Psychosis Flashcards
(42 cards)
Absorbption, distribution, and metabolism of anti-psychotics
Oral absorption is incomplete with significant first-pass effect
Highly lipid solubility leads to concentration in the CNS, which extends clinical half-life beyond plasma half-life; crosses placenta
Metabolized to polar substance for excretion by hepatic CYP450; can be excreted in breast milk
Dosage formulations for antipsychotics
Oral - immediate release for chronic dosing, 1-2x/day
IM - for rapid treatment of acute psychosis or for patients who can’t take oral meds
IM depot - improves adherence to maintenance therapy; administered every 2-4 weeks
Typical antipsychotics - Mechanism
High D2/5HT2A blocking ratio
Good D2 block is associated with high efficacy against positive symptoms AND high incidence of extrapyramidal side effects
Typical antipsychotics - agents
Haloperidol - High clinical potency due to greater D2 blocking activity; effective in lower doses but higher risk of EPS
Chlorpromazine - Lower clinical potency due to lesser D2 blocking activity; less risk of EPS but higher doses produce other side effects including antimuscarinic (dry mouth, tachycardia, urinary retention, constipation), alpha-1 blockade (hypotension) and antihistamine (sedation)
Atypical antipsychotics - Mechanism
Low D2/5HT2A blocking ratio - associated with better efficacy against negative symptoms and increased efficacy in treatment-resistant individuals
Atypical antipsychotics - Agents
Clozapine
Risperidone
Olanzapine
Aripiprazole
Clozapine
Atypical antipsychotic effective in patients who are refractory to other drugs
Reserved for this indication due to 1-2% incidence of agranulocytosis
Extrapyramidal symptoms
Caused by dopaminergic blockade; high with Haloperidol
Acute dystonia - treated with antimuscarinic agents
Akathisia - motor restlessness, inability to sit still
Pseudoparkinsonism (tremor, bradykinesia, rigidity) - treated with anticholinergic agents or Amantadine
Tardive dyskinesias
Tardive dyskinesias
Extrapyramidal symptom with onset 3-6 months; characterized by involuntary, repetitive movement of lips and tongue with chorea of arms and legs
May worsen with withdrawal of the antipsychotic drug and is usually irreversible; overall incidence 20-40% with chronic treatment
Other side effects of antipsychotic agents
Metabolic effects via block of hypothalamic DA receptors - Type 2 DM, weight gain, hypertension, hyperglycemia, hypercholesterolemia; more common with atypical agents
Altered thermoregulation via block of hypothalamic DA
Lowered seizure threshold
Tricyclic antidepressants - Agents
Amitriptyline
Imipramine
Desipramine
SSRIs - Agents
Fluoxetine
Paroxetine
Sertraline
Citalopram
Buproprion - Mechanism & Side effects
NE and DA reuptake inhibitor (NDRI)
Side effects: anxiety, insomnia, higher seizure risk; contraindicated in patients with eating disorders or history of seizures
No sexual side effects, weight neutral
Venlafaxine - Mechanism & Side effects
5HT and NE reuptake inhibitor (SNRI)
Side effects: Diastolic hypertension Sweating Sexual side effects Withdrawal syndrome with "electric shock" sensation
Trazodone - Mechanism
Serotonin antagonist / reuptake inhibitor (SARI)
Weak antidepressant, mainly used for insomnia
Side effects: drowsiness, dizziness
TCADs - Mechanism
Blocks reuptake of NE, 5HT and DA (at high doses)
Also blocks H1 histaminic, muscarnic cholinergic, and alpha-1 receptors
SSRIs - Side effects
Acute (diminish over time): Nausea, diarrhea, insomnia, dry mouth
Chronic: Weight gain, sexual dysfunction, cognitive blunting
Flu-like withdrawal syndrome
DDIs with MAOIs & inhibitors of CYP450
TCADs - Side effects
Anticholinergic effects (blurred vision, constipation, dry mouth, urinary retention, glaucoma)
Orthostasis
Weight gain
Sexual side effects
Fatal in overdose due to seizure and cardiac arrhythmia
MAOIs - Mechanism
Blocks degradation pathway for NE and 5HT, allowing greater release into the synapse; inhibition is irreversible and persists after drug is no longer detectable in the plasma
Effective in non-responsive patients, especially atypical depression
MAOIs - Adverse Effects
Anti-cholinergic (dry mouth, constipation, urinary retention)
Sexual side effects
Weight gain
Overdose causing seizures, shock, hyperthermia
MAOI DDIs
Interaction with foods high in tyramine (liver/beer/wine/cheese); tyramine displaces NE from storage vesicles causing excessive NE release leading to hypertensive crisis
Interaction with SSRIs/SNRIs, Medperdine (Demerol), and Dextromethorphan (cough suppressant) causing serotonin syndrome
Serotonin syndrome
Increased serotonin in the CNS causes over-stimulation of 5HT2A receptors
Presents as tremor, tachycardia, hypertension, sweating, dilated pupils, hyperreflexia, clonus, and hyperthermia causing metabolic acidosis, rhabdomyolysis, seizures, renal failure, and DIC
Mirtazapine - Mechanism, Uses, and Side effects
Mechanism: Blocks a-2 receptors on serotonergic and adrenergic neurons, enhancing release of 5HT and NE; does NOT affect reuptake systems
Useful due to additional anti-insomnia and anti-anxiety effects; low incidence of sexual side effects
Side effects: Daytime somnolence, weight gain
Benefits of Lithium
Best studied, best proven drug for bipolar disorder
Effective anti-manic, reasonable preventative agent, some antidepressant and anti-suicidal properties
Neuro-regenerative
Cheap